DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more



Cohort Study for Patients Using Fuzeon (Enfuvirtide)

Information source: Institute for Interdisciplinary Infectiology
Information obtained from ClinicalTrials.gov on June 20, 2008
Link to the current ClinicalTrials.gov record.

Condition(s) targeted: HIV Infections; Antiretroviral Treatment

Intervention: Fuzeon (Enfuvirtide) (Drug); Laboratory diagnostic (CD4-cells) (Procedure); Laboratory diagnostics (HIV-1 viral load) (Procedure); antiretroviral co-medication beside Fuzeon (Drug)

Phase: N/A

Status: Active, not recruiting

Sponsored by: Institute for Interdisciplinary Infectiology

Official(s) and/or principal investigator(s):
Andreas Plettenberg, MD, Study Chair, Affiliation: ifi-Institute for Interdisciplinary Infectiology

Summary

The Radata-Fuzeon cohort is an observational cohort study to gain a better understanding of Fuzeon (Enfuvirtide) in daily clinical practice. Patients planned to take this drug in a new antiretroviral combination therapy (ART) are eligible to participate in this observation.

Physicians may register patients online via the internet. They are offered to get an expert advice suggesting therapeutics for a new ART.

Observation interval is every three month. However physicians are allowed to initiate new diagnostics, expert advice and therapeutic changes independently from these intervals if necessary.

Total observation time for each patients is planned for two years.

Clinical Details

Official title: The Radata-Fuzeon Cohort - An Observational Cohort-Study in HIV-Infected Patients Using Fuzeon (Enfuvirtide) as Part of Their Antiretroviral Combination Therapy

Study design: Natural History, Longitudinal, Convenience Sample, Retrospective/Prospective Study

Eligibility

Minimum age: N/A. Maximum age: N/A. Gender(s): Both.

Criteria:

Inclusion Criteria:

- Diagnosis of HIV-Infection

- Planned to switch to a Fuzeon-containing antiretroviral therapy

Exclusion Criteria:

- Inability to understand or sign inform consent

Locations and Contacts

Ifi-Institute for Interdisciplinary Infectiology, Hamburg D-20099, Germany
Additional Information

Radata-Homepage (German language)

Starting date: May 2003
Ending date: December 2006
Last updated: October 21, 2005

Page last updated: June 20, 2008

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2012